No Data
No Data
Analysts Conflicted on These Healthcare Names: Halozyme (HALO), Stoke Therapeutics (STOK) and Lantheus (LNTH)
Stocks With the Largest Increases and Decreases in Short Interest Since the Elections – Goldman
Lantheus to Present at Upcoming Investor Conferences
Earnings Preview: Lantheus to Report Financial Results Pre-market on February 26
Express News | Lantheus Holdings Inc : Leerink Partners Raises Target Price to $125 From $122
Why Investors Shouldn't Be Surprised By Lantheus Holdings, Inc.'s (NASDAQ:LNTH) Low P/E